Revelation Biosciences- Units (1 Ord share & 1 War) Accounts Payable

The latest accounts payable for REVBU is $830K as of March 2026. That compares with $630K in the prior-year period — up 32.5% year over year. Investors often review this figure alongside Revelation Biosciences- Units (1 Ord share & 1 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REVBU's accounts payable moved from $630K to $830K — a 32.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Revelation Biosciences- Units (1 Ord share & 1 War)'s operating scale or balance-sheet position.

A accounts payable figure of $830K for REVBU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REVBU's accounts payable ($830K), review year-over-year change from $630K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.